Received: 3 February 2021
Accepted: 3 May 2021
First Online: 17 May 2021
: These laboratory dose confirmation studies were conducted in compliance with local and national regulatory requirements, including approval by the study site animal care and use committee, and were consistent with the principles of Good Clinical Practices (VICH guideline on good clinical practice [GCP; VICH GL 9]), cited VICH referenced anthelmintic guidelines as well as cited and referenced World Association for the Advancement of Veterinary Parasitology (WAAVP) anthelmintic guidelines.
: Not applicable.
: LMY, SW, EC and DES are current or former employees of Elanco Animal Health. DDB and CRR were contracted as the study investigator and/or the contracted veterinary parasitologist for each laboratory study. Some of the handling editors have been involved in consulting services (Filipe Dantas-Torres), research projects (Filipe Dantas-Torres, Adnan Hodži#) and meetings (Filipe Dantas-Torres) sponsored by different veterinary pharmaceutical companies in the past 10 years, including Elanco. They declare that each manuscript in this collection was handled impartially and peer reviewed rigorously by at least two independent external reviewers. The other handling editors (Alicia Rojas) declare that they have no competing interests.